Pfizer-BioNTech COVID-19 Vaccine COMIRNATY® Receives Full …
WEBAug 23, 2021 · The Pfizer-BioNTech COVID-19 Vaccine has received EUA from FDA to: prevent COVID-19 in individuals 12 years of age and older, and; provide a third dose to individuals 12 years of age and older who have been determined to have certain kinds of immunocompromise
Pfizer and BioNTech Receive U.S. FDA Approval for 2023-2024 …
WEBSep 11, 2023 · The U.S. FDA approved and granted emergency use authorization for the companies' updated monovalent vaccine for the 2023-2024 season. The vaccine is indicated as a single dose for most individuals 5 years of age and older and offers improved protection against multiple Omicron-related sublineages.
Pfizer and BioNTech Announce Positive Topline Data for mRNA …
WEBOct 26, 2023 · The companies announced positive topline results from a Phase 1/2 study of their combination vaccine candidates against influenza and COVID-19. The vaccine candidates induced robust immune responses to influenza and SARS-CoV-2 strains and had a safety profile similar to the COVID-19 vaccine.
FDA Approves and Authorizes Updated mRNA COVID-19 Vaccines …
WEBThe updated mRNA COVID-19 vaccines include Comirnaty and Spikevax, both of which are approved for individuals 12 years of age and older, and the Moderna COVID-19 Vaccine …
FDA Approves First COVID-19 Vaccine | FDA - U.S. Food and Drug ...
WEBFDA approved the first COVID-19 vaccine, which has been known as the Pfizer-BioNTech COVID-19 Vaccine, and is now marketed as Comirnaty (koe-mir’-na-tee), for the …
FDA Approves Pfizer Vaccine: Live Updates - The New York Times
WEBThe F.D.A. grants full approval to the Pfizer-BioNTech Covid-19 vaccine. N.Y.C. will require shots for all education staff, including teachers and principals. ... At the news …
Pfizer and BioNTech Receive Positive CHMP Opinion for Omicron …
WEBSep 20, 2024 · NEW YORK & MAINZ, Germany, September 20, 2024--Pfizer Inc. (NYSE: PFE, "Pfizer") and BioNTech SE (Nasdaq: BNTX, "BioNTech") today announced that the Committee for Medicinal Products for Human Use ...
Pfizer and BioNTech Announce Further Details on …
WEBApr 9, 2020 · BioNTech and Pfizer announce details of their partnership to advance mRNA vaccine candidates for COVID-19, with the goal of global access and supply. The collaboration involves joint clinical trials, manufacturing, and commercialization, with potential milestone payments for BioNTech.
‘Incredible milestone for science.' Pfizer and BioNTech update …
WEBThe Pfizer/BioNTech collaboration says it will submit "within days" a request to the U.S. Food and Drug Administration for emergency use authorization (EUA) of its vaccine. ...
Coronavirus (COVID-19) Update: FDA Authorizes Pfizer-BioNTech …
WEBThe FDA expanded the emergency use authorization (EUA) for the Pfizer-BioNTech COVID-19 Vaccine for the prevention of coronavirus disease 2019 (COVID-19) caused …
- Some results have been removed